Psilocybin, ketamine, LSD, and ibogaine possess the strongest anti-aging properties among psychedelics, whereas heroin, methamphetamine, cocaine, and fentanyl accelerate aging.
"So yeah, it was if I remember correctly psilocybin, ketamine, LSD, uh ibogaine, and then I think the ones clearly that did not have anti-aging, actually were aging, were heroin, meth, cocaine, fentanyl is not an anti-aging." (said at 0:42:23)
The assertion that psilocybin, ketamine, LSD, and ibogaine possess strong anti-aging properties overstates very preliminary experimental and observational evidence, while the assertion that illicit stimulants and opioids accelerate biological aging is consistent with observational literature. Small pilot trials have observed decreases in next-generation epigenetic aging markers following ketamine infusion therapy in patients with depression or PTSD, and rodent work has explored psilocybin on lifespan; however, robust clinical evidence demonstrating anti-aging or life-extension effects in humans is lacking for psilocybin, LSD, and ibogaine. Conversely, epidemiological and epigenetic clock studies consistently demonstrate that chronic exposure to substances such as opioids (heroin, fentanyl), methamphetamine, and cocaine is associated with significant biological and epigenetic age acceleration.
- supports: Epigenetic clock analysis in methamphetamine dependence. (Psychiatry research 2022)
"Following adjustment for confounding factors, MA dependence was significantly associated with accelerations in PhenoAge, GrimAge, and DNAmTL, as well as alterations in DNAm-based age-predictive factors (beta-2-microglobulin, granulocytes, and naive cluster of differentiation 4+ T cells)." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Epigenetic aging and DNA methylation biomarker changes following ketamine treatment in pat… (Translational psychiatry 2025)
"We observed a reduction in epigenetic age in the OMICmAge, GrimAge V2, and PhenoAge biomarkers." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Psilocybin and human longevity. (npj aging 2026)
"These findings highlight the need for rigorous mechanistic and epidemiological studies before inferring human anti-aging effects of psychedelics." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Substance use and epigenetic age acceleration: Associations with alcohol, tobacco, illicit… (Drug and alcohol dependence 2026)
"Binary measures of illicit opioid use (β=0.417, p = 5.913e-11; β=0.180, p = 0.010) and non-prescription opioid use (β=0.264, p = 1.744e-09; 0.001; β=0.127, p = 0.008), as well as a continuous measure of SUD severity (β=0.061, p = 6.608e-06; β=0.039, p = 0.008) were positively associated with AgeAccelGrim2 and DunedinPACE, respectively." (abstract, results, passage verified)
pubmedfull study (doi)